Miragen Therapeutics Inc

NASDAQ:MGEN  
16.82
+0.61 (+3.76%)
Other Pre-Announcement, Equity Financing / Related

Miragen Posts Q3 Loss Per Share $0.10

Published: 11/10/2020 22:37 GMT
Miragen Therapeutics Inc (MGEN) - Miragen Reports Third Quarter 2020 Financial Results and Provides Corporate Updates.
Q3 Loss per Share $0.10.
Q3 Earnings per Share Estimate $-0.13 -- Refinitiv Ibes Data (analyst estimates).
Plans to Effect a Reverse Stock Split of Its Shares of Common Stock at a Ratio of 1-for-15.
Anticipates Stock Split Will Be Effective As of November 12, 2020.
Trading of Common Stock Will Begin on a Split-adjusted Basis When Markets Open on November 13, 2020.